June 2016 - Evolution Biotechnologies
archive,date,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-16.4,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Bedford, UK, and Austin, Texas; June 10,  2016 Evolution Biotechnologies (www.evolutionbiotech.com), the company working to expand the use of biological control into medically important areas, today announced the formation of its US-based subsidiary, Evolution Biotechnologies Inc. of Delaware. The company has been established to support operations at the planned company facility in Austin, Texas. Aaron Gunn, Chief Operating Officer of Evolution, said “This is an important step for the company, and will help facilitate our expansion into the United States.”   About Evolution Biotechnologies Evolution Biotechnologies (UK company 09473027 / US company 6050853) has been established to extend the application of biological control from its...